Alectinib and Brigatinib: New Second-Generation ALK Inhibitors for the Treatment of Non–Small Cell Lung Cancer
Journal of the Advanced Practitioner in Oncology
doi 10.6004/jadpro.2018.9.1.8
Full Text
Open PDFAbstract
Available in full text
Date
February 1, 2018
Authors
Publisher
Harborside Press, LLC